Brexit

News

Stop tinkering and invest in R&D, UK pharma tells government

Senior scientists from the UK’s two big pharma companies GlaxoSmithKline and AstraZeneca say only a rapid and significant increase in government R&D spending will boost the UK life

Views & Analysis

Pharma and med device sectors being forced into Hard Brexit ...

Brexit is already forcing parts of the medical device sector to leave the UK – will pharma have to follow?

News

EMA spends in anticipation of Brexit staff losses

Europe’s drugs regulator has issued a temporary staffing contract worth up to £32 million, in order to ensure it has enough hands on deck while it relocates from London as part of Brexit.

News